View Clinical Trial (Medical Research Study)


A Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Adjunctive Xalatan® Eye Drops in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG) - NCT01037036-94025(Clinical Trial 447933)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Menlo Park
State:  
CA
Zip Code: 94025
Conditions: Ocular Hypertension - Open-Angle Glaucoma
Purpose: The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.
Study summary:
Criteria: Inclusion Criteria: - Over 18 years - Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension - Currently on prostaglandin therapy Exclusion Criteria: - Uncontrolled medical conditions - Subjects who wear contact lenses - Subjects requiring chronic topical artificial tears, lubricants, and /or - requiring any other chronic topical medications
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: February 17, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.